Treatment Horizons

Treatment Horizons

Skin Cancers Revisited

Sun Blocked A new study examines non-melanoma skin cancers & HIV by Chael Needle In the pre-HAART era, an AIDS diagnosis or even an HIV-positive diagnosis illuminated...

Care Crusade

HIVHealthReform.org offers chances to learn about & advocate for new policies by Chael Needle The Patient Protection and Affordable Care Act, created by the Obama administration,...

Status Update

LifeGuide Based in San Diego, a prevention model aims to reach everyone Everybody should be tested for HIV. That message is the basis for Lead...

Borrowing Therapies

Two Anti-Cancer Drugs Are Tapped in the Fight Against HIV by Chael Needle New types of drugs are needed in the fight against HIV but some of...

Cuts to Healthcare

Treatment Horizons by Chael Needle Hill & Mountain? Weakened federal support of HIV/AIDS services puts our health at risk President Obama’s fiscal year 2014 budget plan includes...

Expanded Portfolio

A new study reports on the drug-drug interaction between pitavastatin and a common PI combo by Chael Needle Last year, A&U reported on a study that...

TANGO Study Starts

In February 2018, ViiV Healthcare announced the start of a forty-eight-week phase III study designed to determine whether adults with HIV-1 who have achieved...

Use of HIV Preexposure Prophylaxis May Increase Use of Primary Care

A new study reveals that patients who use PrEP (Pre-exposure Prophylaxis ), a combination of the antiretroviral medications emtricitabine and tenofovir called Truvada, to...

Janssen Announces FDA Approval of SYMTUZA

The Janssen Pharmaceutical Companies of Johnson & Johnson announced on July 18, 2018 that the U.S. FDA has approved the use of SYMTUZA, the...

LATEST POSTS

An Aspirin A Day May Keep HIV Away

The Journal of the International AIDS Society (JIAS) has published the results of a study conducted by researchers from the universities of Manitoba, Waterloo...

Pride In Spite of It All

Let’s Talk About PrEP